USDOL has announced a proposed rule intended to clarify the "fluctuating workweek" under the FLSA.
USDOL has maintained a very busy agenda for the end of 2018 and the beginning of 2019, but recent action plans released by the President show that we may be in for additional, significant regulatory changes in the future.
The 6th Circuit U.S. Court of Appeals might review a federal judge's decision to defer to one of the U.S. Labor Department's April 2011 fluctuating-workweek assertions.
It is more important than ever to be clear-headed and articulate in opposing the proliferation of the U.S. Labor Department's muddled misconception that bonuses are supposedly "incompatible" with fluctuating-workweek pay plans.
The U.S. Supreme Court ruled today that GlaxoSmithKline's pharmaceutical sales representatives were exempt from overtime pay under the FLSA's "outside salesman" exemption.